Changes in gene expression during Mallory body induction in drug-primed mice livers

Y. Nagao, Yu-Jui Yvonne Wan, Q. X. Yuan, S. W. French

Research output: Contribution to journalArticle

Abstract

To clarify the mechanism of Mallory body (MB) formation, we studied changes in gene expression related to MB and hepatocellular proliferation, using a mouse model fed diethyl 1,4-dihydro-1,4,6-trimethyl-3,5-pyridinedicarboxylate(DDC) for 5 month, followed by withdrawal of DDC for 1 month, then refed for 1,3,5 days, which induces MB formation and hepatocellular proliferation (Yuan et el, Hepatology 24;603-621, 1996). Cytokeratin (CK) 55, tissue transglutaminase (TG) and ubiquitin (UB) mRNA expression was increased by DDC-refeeding. c-jun and c-myc mRNAs were also induced. The pattern of c-jun mRNA expression correlated with an increase in CK55 and TG mRNA. c-myc mRNA expression did not correlate. Hepatocyte growth factor-activator (HGF-A) mRNA expression was not increased during MB formation. The expression of peroxisome proliferator activated receptor α (PPARα) and retinoid x receptor α (RXRα) mRNAs were negatively correlated with the expression of CK55, TG and c-jun mRNA. The data suggest the possibility that MB formation may be regulated by the c-jun product as a transcriptional factor through c-jun induced up-regulation of CK55. The stimulation of hepatocellular proliferation may have a different pathway from MB induction. The latter appears to repress the direct hyperplasia pathway related to PPARα and RXRα.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number3
StatePublished - 1997

Fingerprint

Mallory Bodies
protein-glutamine gamma-glutamyltransferase
Gene expression
Liver
retinoids
Gene Expression
drugs
gene expression
Messenger RNA
liver
mice
Pharmaceutical Preparations
hepatocyte growth factor
receptors
refeeding
ubiquitin
hyperplasia
Peroxisome Proliferator-Activated Receptors
Transglutaminases
Retinoids

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Changes in gene expression during Mallory body induction in drug-primed mice livers. / Nagao, Y.; Wan, Yu-Jui Yvonne; Yuan, Q. X.; French, S. W.

In: FASEB Journal, Vol. 11, No. 3, 1997.

Research output: Contribution to journalArticle

@article{98df1a828957485dbc5c5551ea37be47,
title = "Changes in gene expression during Mallory body induction in drug-primed mice livers",
abstract = "To clarify the mechanism of Mallory body (MB) formation, we studied changes in gene expression related to MB and hepatocellular proliferation, using a mouse model fed diethyl 1,4-dihydro-1,4,6-trimethyl-3,5-pyridinedicarboxylate(DDC) for 5 month, followed by withdrawal of DDC for 1 month, then refed for 1,3,5 days, which induces MB formation and hepatocellular proliferation (Yuan et el, Hepatology 24;603-621, 1996). Cytokeratin (CK) 55, tissue transglutaminase (TG) and ubiquitin (UB) mRNA expression was increased by DDC-refeeding. c-jun and c-myc mRNAs were also induced. The pattern of c-jun mRNA expression correlated with an increase in CK55 and TG mRNA. c-myc mRNA expression did not correlate. Hepatocyte growth factor-activator (HGF-A) mRNA expression was not increased during MB formation. The expression of peroxisome proliferator activated receptor α (PPARα) and retinoid x receptor α (RXRα) mRNAs were negatively correlated with the expression of CK55, TG and c-jun mRNA. The data suggest the possibility that MB formation may be regulated by the c-jun product as a transcriptional factor through c-jun induced up-regulation of CK55. The stimulation of hepatocellular proliferation may have a different pathway from MB induction. The latter appears to repress the direct hyperplasia pathway related to PPARα and RXRα.",
author = "Y. Nagao and Wan, {Yu-Jui Yvonne} and Yuan, {Q. X.} and French, {S. W.}",
year = "1997",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Changes in gene expression during Mallory body induction in drug-primed mice livers

AU - Nagao, Y.

AU - Wan, Yu-Jui Yvonne

AU - Yuan, Q. X.

AU - French, S. W.

PY - 1997

Y1 - 1997

N2 - To clarify the mechanism of Mallory body (MB) formation, we studied changes in gene expression related to MB and hepatocellular proliferation, using a mouse model fed diethyl 1,4-dihydro-1,4,6-trimethyl-3,5-pyridinedicarboxylate(DDC) for 5 month, followed by withdrawal of DDC for 1 month, then refed for 1,3,5 days, which induces MB formation and hepatocellular proliferation (Yuan et el, Hepatology 24;603-621, 1996). Cytokeratin (CK) 55, tissue transglutaminase (TG) and ubiquitin (UB) mRNA expression was increased by DDC-refeeding. c-jun and c-myc mRNAs were also induced. The pattern of c-jun mRNA expression correlated with an increase in CK55 and TG mRNA. c-myc mRNA expression did not correlate. Hepatocyte growth factor-activator (HGF-A) mRNA expression was not increased during MB formation. The expression of peroxisome proliferator activated receptor α (PPARα) and retinoid x receptor α (RXRα) mRNAs were negatively correlated with the expression of CK55, TG and c-jun mRNA. The data suggest the possibility that MB formation may be regulated by the c-jun product as a transcriptional factor through c-jun induced up-regulation of CK55. The stimulation of hepatocellular proliferation may have a different pathway from MB induction. The latter appears to repress the direct hyperplasia pathway related to PPARα and RXRα.

AB - To clarify the mechanism of Mallory body (MB) formation, we studied changes in gene expression related to MB and hepatocellular proliferation, using a mouse model fed diethyl 1,4-dihydro-1,4,6-trimethyl-3,5-pyridinedicarboxylate(DDC) for 5 month, followed by withdrawal of DDC for 1 month, then refed for 1,3,5 days, which induces MB formation and hepatocellular proliferation (Yuan et el, Hepatology 24;603-621, 1996). Cytokeratin (CK) 55, tissue transglutaminase (TG) and ubiquitin (UB) mRNA expression was increased by DDC-refeeding. c-jun and c-myc mRNAs were also induced. The pattern of c-jun mRNA expression correlated with an increase in CK55 and TG mRNA. c-myc mRNA expression did not correlate. Hepatocyte growth factor-activator (HGF-A) mRNA expression was not increased during MB formation. The expression of peroxisome proliferator activated receptor α (PPARα) and retinoid x receptor α (RXRα) mRNAs were negatively correlated with the expression of CK55, TG and c-jun mRNA. The data suggest the possibility that MB formation may be regulated by the c-jun product as a transcriptional factor through c-jun induced up-regulation of CK55. The stimulation of hepatocellular proliferation may have a different pathway from MB induction. The latter appears to repress the direct hyperplasia pathway related to PPARα and RXRα.

UR - http://www.scopus.com/inward/record.url?scp=33750161945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750161945&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750161945

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -